AHernando_Calvo
@AhernandoCalvo
Followers
308
Following
518
Statuses
242
Clinician scientist at @vallhebron Phase 1 and Cancer Genomics Group @VHIO. Former med onc fellow at @pmcancercentre, Phase1/Head and Neck, biomarkers.
Joined March 2020
Thank you @myESMO for highlighting our recent publication in @eClinicalMed unveiling dowstream effects of performing #NGS in pts with advanced solid tumors enrolled in OCTANE. Very nice summary! 👇 👇
0
2
15
RT @VHIO: 🔬Esta semana hemos sabido que un estudio de @Genomicslab_ y la #UITM-@CaixaResearch del VHIO muestra que combinar la firma génica…
0
3
0
RT @VHIO: 🧑🏻⚕️ @AhernandoCalvo , @vallhebron, #UITM @CaixaResearch i @Genomicslab_ VHIO, rep una beca @GileadSciences per validar l’eina #…
0
1
0
📍Happy to share this publication @JCOPO_ASCO validating VIGex signature in the INSPIRE trial. Improved predictive performance for IO benefit was observed with VIGex+ctDNA dynamics in this international collaboration 🇨🇦 🇪🇸@pmcancercentre @VHIO @vallhebron
0
3
17
Phase II, open-label, randomized trial of durvalumab with olaparib or cediranib in pts with pMMR CRC or pancreatic cancer at @pmcancercentre. Mentorship from Aaron Hansen and @lillian_siu and support from @PughLab @bhaibeka labs @OICR_news and others!
1
2
12
@cabify_espana Taxi reservado con anterioridad en Barcelona para las 7:10. Mensaje de conductor en camino llegada en 49 minutos (a las 6:50). El mismo conductor que habia aceptado mi reserva esta en curso de otro trayecto sabiendo que llegará tarde. Segunda vez en el mismo mes.
4
0
1
@Lawson_Eng @rayychan @CheungYT_HK @alexchan928 @ChinMelissa @pmcancercentre @PMResearch_UHN @UofT_DoM @UHN @CancerCareMASCC @SurvOncMASCC Congratulations Lawson! Brilliant career ahead
1
0
2
RT @oncodaily: Findings from a first-in-human phase I study investigating IBI363 - @ESMO
@AhernandoCalvo @vallhebron @VHIO @pmcancercentre…
0
3
0
📍Stay tuned for today´s session with both clinical insights and AACR expert commentary
Missed yesterday's session? 👉 Stay up to date with innovative #immunotherapy approaches and engage with the panel of expert presenters by submitting your questions live. #ESMOVirtualPlenary 🔗
0
0
4
RT @myESMO: #ESMOVirtualPlenary: Safety & efficacy of a PD-1/IL-2 bispecific antibody fusion protein show proof-of-concept on its capacity…
0
1
0
0
0
1
Happy to share our last review in Cancer Treatment Reviews. Big support from @AliceRossiMD , Maria Vieito, Emile Voest @NKI_nl and Elena Garralda @VHIO 🙌Exciting times for tumor agnostic therapies but also many challenges lying ahead
0
4
11
RT @AACR: AACR members have elected #AACRFellows Lillian L. Siu, MD, as their 2024-2025 President-Elect. Dr. Siu will become President-Elec…
0
33
0
Happening now at @WIN_Consortium. Potential applications of AI in liquid biopsies an precission oncology. We are only in the tip of the iceberg.
0
1
2
RT @weldeiry: Great to see colleagues from Tokyo, VHIO in Barcelona, Kinghorn in Australia and Fudan University in Shanghai. @WIN_Consorti…
0
4
0
📡Happening now at @WIN_Consortium 2024 symposium in @AbuDhabi_ADM. Amazing efforts within the the Emirati Genome Program led by @ikjow with over 50.000 genomes profiled. So far, no arab genomes are being used as reference for mutation variant calling. Limitation to be aware 🧐
0
0
1
Keynote lecture from Prof @weldeiry new chair at @WIN_Consortium 2024 symposium in @AbuDhabi_ADM . Importance of the Tumor Board and n-of-1 clinical trials for personalizing cancer care and the success history of the WINTHER trial where @VHIO had a pivotal role
0
7
9
Keynote lecture Prof Humaid Al Shamsi @alshamsi2000 at @WIN_Consortium symposium 2024. Very comprehensive view on #cancer trends in the United Arab Emirates.
0
1
3